BICYCLE THERAPEUTICS PLC-ADR (BCYC) Stock Income Statement
NASDAQ:BCYC - Nasdaq - US0887861088 - ADR - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 35.27M | 26.98M | 14.46M | 11.70M | 10.39M | |||
| Operating Expenses | 244.43M | 216.33M | 130.56M | 77.68M | 62.93M | |||
| Research and Development | 172.97M | 156.50M | 81.61M | 44.88M | 33.15M | |||
| Selling, General, and Administrative Expenses | 71.46M | 59.83M | 48.95M | 32.79M | 29.78M | |||
| Operating Income | -209.15M | -189.35M | -116.09M | -65.98M | -52.54M | |||
| Interest Income/Expense | 31.84M | 10.14M | 1.85M | -2.50M | 810.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Non Recurring Items | 3.52M | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -173.80M | -179.21M | -114.24M | -68.48M | -51.73M | |||
| Income Tax | -4.76M | 1.46M | -1.52M | -1.66M | -720.00K | |||
| Net Income | -169.03M | -180.66M | -112.72M | -66.82M | -51.01M | |||
| EBITDA | -201.98M | -182.81M | -112.40M | -64.57M | -51.26M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.90 | -5.07 | -3.80 | -2.67 | -2.66 | |||
| Non GAAP EPS | -2.95 | -5.13 | -3.80 | -2.69 | -2.65 | |||
| Statistics | ||||||||
| Profit Margin | -479.18% | -669.72% | -779.53% | -571.11% | -490.95% | |||
| Operating Profit Margin | -592.92% | -701.93% | -802.84% | -563.93% | -505.68% | |||
All data in USD